Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
March 1, 1988
Renin inhibitors containing psi[CH2O] pseudopeptide inserts
R E TenBrink, D T Pals, D W Harris, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1991
Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates
D T Pals, G L DeGraaf, S J Couch, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1993
Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates
G L DeGraaf, D T Pals, S J Couch, et al.
Biochemistry
|
August 1, 1972
Angiotensin I converting enzyme of calf lung. Method of assay and partial purification
R L Stevens, E R Micalizzi, D C Fessler, et al.
Journal of Medicinal Chemistry
|
May 1, 1990
Renin inhibitory peptides. A beta-aspartyl residue as a replacement for the histidyl residue at the P-2 site
S Thaisrivongs, B Mao, D T Pals, et al.
Journal of Medicinal Chemistry
|
November 1, 1985
Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors
S Thaisrivongs, D T Pals, W M Kati, et al.
Journal of Medicinal Chemistry
|
October 1, 1986
Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo
S Thaisrivongs, D T Pals, D W Harris, et al.
Journal of Medicinal Chemistry
|
March 1, 1987
alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model
S Thaisrivongs, D T Pals, J A Lawson, et al.
Journal of Medicinal Chemistry
|
October 1, 1972
Angiotensin II antagonism. Structure-activity relationships of 8-substituted angiotensin II analogs
D C Fessler, F Slipos, G S Denning, et al.
Journal of Medicinal Chemistry
|
June 1, 1987
Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid
S Thaisrivongs, D T Pals, L T Kroll, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
March 1, 1988
Renin inhibitors containing psi[CH2O] pseudopeptide inserts
R E TenBrink, D T Pals, D W Harris, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1991
Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates
D T Pals, G L DeGraaf, S J Couch, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1993
Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates
G L DeGraaf, D T Pals, S J Couch, et al.
Biochemistry
|
August 1, 1972
Angiotensin I converting enzyme of calf lung. Method of assay and partial purification
R L Stevens, E R Micalizzi, D C Fessler, et al.
Journal of Medicinal Chemistry
|
May 1, 1990
Renin inhibitory peptides. A beta-aspartyl residue as a replacement for the histidyl residue at the P-2 site
S Thaisrivongs, B Mao, D T Pals, et al.
Journal of Medicinal Chemistry
|
November 1, 1985
Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors
S Thaisrivongs, D T Pals, W M Kati, et al.
Journal of Medicinal Chemistry
|
October 1, 1986
Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo
S Thaisrivongs, D T Pals, D W Harris, et al.
Journal of Medicinal Chemistry
|
March 1, 1987
alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model
S Thaisrivongs, D T Pals, J A Lawson, et al.
Journal of Medicinal Chemistry
|
October 1, 1972
Angiotensin II antagonism. Structure-activity relationships of 8-substituted angiotensin II analogs
D C Fessler, F Slipos, G S Denning, et al.
Journal of Medicinal Chemistry
|
June 1, 1987
Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid
S Thaisrivongs, D T Pals, L T Kroll, et al.
Page
of 5